glp-1 for ibs-d Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis it’s the perfect companion for anyone using GLP GLP-1 Therapy and IBS: Safety
Description
Slow, attentive eating and regular sleep patterns align with GLP-1's circadian rhythm
doi: 10.2147/POR.S471476
Within just an hour of taking it on an empty stomach, studies show up to ~30% less hunger, ~40% fewer cravings and ~18% lower calorie intake
Mental Health Support Holistic Well-being: Weight loss is as much a mental journey as a physical one
doi: 10.1016/j.cell.2016.05.011
53 Novel triple-G agonists Retatrutide is a novel, once-weekly injectable agent that acts on GIP, GLP-1 and glucagon receptors, and has shown promise in clinical trials for significant weight loss
